TY - JOUR AU - Loufouma-Mbouaka, A. AU - Andor, A. AU - Leitsch, D. AU - Pérez-Serrano, J. AU - Arnér, E.S.J. AU - Walochnik, J. AU - Martín-Pérez, T. KW - Acanthamoeba castellanii KW - Auranofin KW - Redox system KW - Selenoprotein KW - Thioredoxin reductase KW - Thioredoxin reductase inhibitor T1 - Evaluating the amoeba thioredoxin reductase selenoprotein as potential drug target for treatment of Acanthamoeba infections LA - eng PY - 2024/12/01/ T2 - International Journal for Parasitology: Drugs and Drug Resistance SN - 2211-3207 VL - 26 PB - Elsevier Ltd AB - The genus Acanthamoeba comprises facultative pathogens, causing Acanthamoeba keratitis (AK) and granulomatous amoebic encephalitis (GAE). In both diseases, treatment options are limited, and drug development is challenging. This study aimed to investigate the role of the large thioredoxin reductase selenoprotein of Acanthamoeba (AcTrxR-L) as a potential drug target assessing the effects of the thioredoxin reductase inhibitors auranofin, TRi-1, and TRi-2 on AcTrxR-L activity and on the viability of Acanthamoeba trophozoites. Recombinant expression and purification of AcTrxR-L as a selenoprotein allowed assessments of its enzymatic activity, with reduction of various substrates, including different thioredoxin isoforms. Auranofin demonstrated potent inhibition towards AcTrxR-L, followed by TRi-1, and TRi-2 exhibiting lower effectiveness. The inhibitors showed variable activity against trophozoites in culture, with TRi-1 and TRi-2 resulting in strongly impaired trophozoite viability. Cytotoxicity tests with human corneal epithelial cells revealed lower susceptibility to all compounds compared to Acanthamoeba trophozoites, underscoring their potential as future amoebicidal agents. Altogether, this study highlights the druggability of AcTrxR-L and suggests it to be a promising drug target for the treatment of Acanthamoeba infections. Further research is warranted to elucidate the role of AcTrxR-L in Acanthamoeba pathogenesis and to develop effective therapeutic strategies targeting this redox enzyme. DO - 10.1016/J.IJPDDR.2024.100564 UR - https://portalcientifico.uah.es/documentos/6702bea10194ce418010f83f DP - Dialnet - Portal de la Investigación ER -